HLA targeting efficiency correlates with human T-cell response magnitude and with mortality from influenza A infection

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 33, 2013, Pages 13492-13497

  Hertz, Tomer ^a   Oshansky, Christine M ^b   Roddam, Philippa L ^c,d,e   DeVincenzo, John P ^c,d,e   Caniza, Miguela A ^b   Jojic, Nebojsa ^f   Mallal, Simon ^g   Phillips, Elizabeth ^g   James, Ian ^g   Halloran, M Elizabeth ^a,h   Thomas, Paul G ^b   Corey, Lawrence ^a,i  

^a Fred Hutchinson Cancer Research Center   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^d LE BONHEUR CHILDREN'S MEDICAL CENTER   (United States)

^e LE BONHEUR CHILDREN S HOSPITAL   (United States)

^f MICROSOFT RESEARCH   (United States)

^g ROYAL PERTH HOSPITAL   (Australia)

^h Department of Biostatistics ^*  (United States)

ⁱ UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HLA ANTIGEN; HLA B ANTIGEN;

ARTICLE; CD8+ T LYMPHOCYTE; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GENE FREQUENCY; HLA SYSTEM; HOSPITALIZATION; HUMAN; HUMAN CELL; INFANT; INFLUENZA A (H1N1); MALE; MORTALITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; T LYMPHOCYTE;

HLA ASSOCIATION; MHC; NATIVE AMERICAN; T-CELL EPITOPE;

CD4-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; COMPUTATIONAL BIOLOGY; ENZYME-LINKED IMMUNOSPOT ASSAY; GENE FREQUENCY; HLA ANTIGENS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INTERFERON-GAMMA; MODELS, STATISTICAL; REGRESSION ANALYSIS;

EID: 84882331569     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1221555110     Document Type: Article

References (54)

1. Jhung MA, et al. (2011) Epidemiology of 2009 pandemic influenza A (H1N1) in the United States. Clin Infect Dis 52(Suppl 1):S13-S26.
2. La Ruche G, et al.; epidemic intelligence team at InVS (2009) The 2009 pandemic H1N1 influenza and indigenous populations of the Americas and the Pacific. Euro Surveill 14(42):19366.
3. Webb SA, et al.; ANZIC Influenza Investigators (2009) Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 361(20):1925-1934.
4. Centers for Disease Control and Prevention (CDC) (2009) Deaths related to 2009 pandemic influenza A (H1N1) among American Indian/Alaska Natives-2 states, 2009. MMWR Morb Mortal Wkly Rep 58(48):1341-1344.
5. Centers for Disease Control and Prevention (CDC) (2009) pandemic influenza A (H1N1) virus infections-Chicago, Illinois, April-July 2009.MMWRMorbMortalWklyRep58(33):913-918.
6. Brooks EG, et al. (2012) 2009 H1N1 fatalities: The New Mexico experience. J Forensic Sci 57(6):1512-1518.
7. Lindstrom S, et al. (2012) Human infections with novel reassortant influenza A(H3N2)v viruses, United States, 2011. Emerg Infect Dis 18(5):834-837.
8. Schaffer A, et al. (2012) The impact of influenza A(H1N1)pdm09 compared with seasonal influenza on intensive care admissions in New South Wales, Australia, 2007 to 2010: A time series analysis. BMC Public Health 12:869.
9. Trauer JM, et al.; Australia, New Zealand and Singapore Pandemic Serosurveillance Study Group (2013) Seroepidemiologic effects of influenza A(H1N1)pdm09 in Australia, New Zealand, and Singapore. Emerg Infect Dis 19(1):92-101.
10. Zarychanski R, et al. (2010) Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection. CMAJ 182(3):257-264.
11. Centers for Disease Control and Prevention (CDC) (2009) Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep 58(19):521-524.
12. Xu R, et al. (2010) Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science 328(5976):357-360.
13. Zhang W, et al. (2010) Crystal structure of the swine-origin A (H1N1)-2009 influenza A virus hemagglutinin (HA) reveals similar antigenicity to that of the 1918 pandemic virus. Protein Cell 1(5):459-467.
14. Gras S, et al. (2010) Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses. Proc Natl Acad Sci USA 107(28):12599-12604.
15. McMichael AJ, Gotch FM, Noble GR, Beare PA (1983) Cytotoxic T-cell immunity to influenza. N Engl J Med 309(1):13-17.
16. Wahl A, et al. (2009) T-cell tolerance for variability in an HLA class I-presented influenza A virus epitope. J Virol 83(18):9206-9214.
17. Dunham EJ, et al. (2009) Different evolutionary trajectories of European avian-like and classical swine H1N1 influenza A viruses. J Virol 83(11):5485-5494.
18. Sun J, Madan R, Karp CL, Braciale TJ (2009) Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat Med 15(3):277-284.
19. Novak EJ, Liu AW, Nepom GT, Kwok WW (1999) MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen. J Clin Invest 104(12):R63-R67.
20. Marshall D, Sealy R, Sangster M, Coleclough C (1999) TH cells primed during influenza virus infection provide help for qualitatively distinct antibody responses to subsequent immunization. J Immunol 163(9):4673-4682.
21. Yap KL, Ada GL, McKenzie IF (1978) Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature 273(5659):238-239.
22. Yap KL, Braciale TJ, Ada GL (1979) Role of T-cell function in recovery from murine influenza infection. Cell Immunol 43(2):341-351.
23. Belz GT, Wodarz D, Diaz G, Nowak MA, Doherty PC (2002) Compromised influenza virusspecific CD8(+)-T-cellmemory in CD4(+)-T-cell-deficient mice. J Virol 76(23):12388-12393.
24. Jordan WS, Jr., Badger GF, Dingle JH (1958) A study of illness in a group of Cleveland families. XVI. The epidemiology of influenza, 1948-1953. Am J Hyg 68(2):169-189.
25. Lee LY-H, et al. (2008) Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest 118(10):3478-3490.
26. Greenbaum JA, et al. (2009) Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc Natl Acad Sci USA 106(48):20365-20370.
27. Tan PT, et al. (2010) Conservation and diversity of influenza A H1N1 HLA-restricted T cell epitope candidates for epitope-based vaccines. PLoS One 5(1):e8754.
28. Tan PT, Khan AM, August JT (2011) Highly conserved influenza A sequences as T cell epitopes-based vaccine targets to address the viral variability. Hum Vaccin 7(4):402-409.
29. Hertz T, et al. (2011) Mapping the landscape of host-pathogen coevolution: HLA class I binding and its relationship with evolutionary conservation in human and viral proteins. J Virol 85(3):1310-1321.
30. Agrati C, et al. (2010) Association of profoundly impaired immune competence in H1N1v-infected patients with a severe or fatal clinical course. J Infect Dis 202(5):681-689.
31. Lambe T, et al. (2012) T-cell responses in children to internal influenza antigens, 1 year after immunizationwithpandemicH1N1influenza vaccine,andresponse to revaccination with seasonal trivalent-inactivated influenza vaccine. Pediatr Infect Dis J 31(6):e86-e91.
32. Richards KA, Chaves FA, Alam S, Sant AJ (2012) Trivalent inactivated influenza vaccines induce broad immunological reactivity to both internal virion components and influenza surface proteins. Vaccine 31(1):219-225.
33. Middleton D, Menchaca L, Rood H, Komerofsky R (2003) New allele frequency database: http://www.allelefrequencies.net. Tissue Antigens 61(5):403-407.
34. European Centre for Disease Prevention and Control (2009) ECDC daily update: 2009 influenza A (H1N1) pandemic. Available at http://ecdc.europa.eu/en/ healthtopics/Documents/100118-Influenza-AH1N1-Situation-Report-0900hrs.pdf. Accessed October 25, 2009.
35. Sidney J, Peters B, Frahm N, Brander C, Sette A (2008) HLA class I supertypes: A revised and updated classification. BMC Immunol 9:1.
36. Sinha N, Roy A, Das B, Das S, Basak S (2009) Evolutionary complexities of swine flu H1N1 gene sequences of 2009. Biochem Biophys Res Comm 390(3):349-351.
37. Valkenburg SA, et al. (2011) Immunity to seasonal and pandemic influenza A viruses. Microbes Infect 13(5):489-501.
38. Carrington M, O'Brien SJ (2003) The influence of HLA genotype on AIDS. Annu Rev Med 54:535-551.
39. Kiepiela P, et al. (2007) CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med 13(1):46-53.
40. Macnamara A, et al. (2010) HLA class I binding of HBZ determines outcome in HTLV-1 infection. PLoS Pathog 6(9):e1001117.
41. Chaturvedi U, Nagar R, Shrivastava R (2006) Dengue and dengue haemorrhagic fever: Implications of host genetics. FEMS Immunol Med Microbiol 47(2):155-166.
42. Moore CB, et al. (2002) Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 296(5572):1439-1443.
43. Vider-Shalit T, Raffaeli S, Louzoun Y (2007) Virus-epitope vaccine design: Informatic matching the HLA-I polymorphism to the virus genome. Mol Immunol 44(6):1253-1261.
44. Bhattacharya T, et al. (2007) Founder effects in the assessment of HIV polymorphisms and HLA allele associations. Science 315(5818):1583-1586.
45. Miura T, et al. (2009) HLA-associated viral mutations are common in human immunodeficiency virus type 1 elite controllers. J Virol 83(7):3407-3412.
46. Miura T, et al. (2009) HLA-B57/B5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognition. J Virol 83(6):2743-2755.
47. Harari A, et al. (2007) Skewed association of polyfunctional antigen-specific CD8 T cell populations with HLA-B genotype. Proc Natl Acad Sci USA 104(41):16233-16238.
48. Tsuji S, et al. (1998) HLA-A24-B07-DRB1 01 haplotype implicated with genetic disposition of peak bone mass in healthy young Japanese women. Hum Immunol 59(4):243-249.
49. Qu H-Q, Polychronakos C (2009) The effect of the MHC locus on autoantibodies in type 1 diabetes. J Med Genet 46(7):469-471.
50. Karan MA, Tascioglu NE, Ozturk AO, Palanduz S, Carin M (2002) The role of HLA antigens in chronic hepatitis B virus infection. J Pak Med Assoc 52(6):253-256.
51. Nakajima S, Kobayashi S, Nohara M, Sato S (1977) HLA antigen and susceptibility to leprosy. Int J Lepr Other Mycobact Dis 45(3):273-277.
52. Dawood FS, et al. (2012) Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: A modelling study. Lancet Infect Dis 12(9):687-695.
53. Rawangkhan A, et al. (2010) Comparison of neuraminidase activity of influenza A virus subtype H5N1 and H1N1 using reverse genetics virus. Southeast Asian J Trop Med Public Health 41(3):562-569.
54. Ghedin E, et al. (2005) Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution. Nature 437(7062):1162-1166.